Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $32.2 million.

  • Qiagen's Change in Accured Expenses rose 5418.24% to $32.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $55.5 million, marking a year-over-year increase of 25643.78%. This contributed to the annual value of $439.5 million for FY2025, which is 801.35% up from last year.
  • Latest data reveals that Qiagen reported Change in Accured Expenses of $32.2 million as of Q4 2025, which was up 5418.24% from $399.0 million recorded in Q3 2025.
  • Over the past 5 years, Qiagen's Change in Accured Expenses peaked at $604.1 million during Q3 2021, and registered a low of -$58.9 million during Q1 2023.
  • In the last 5 years, Qiagen's Change in Accured Expenses had a median value of $395.1 million in 2021 and averaged $282.8 million.
  • Per our database at Business Quant, Qiagen's Change in Accured Expenses crashed by 249533.24% in 2021 and then surged by 209300.18% in 2025.
  • Quarter analysis of 5 years shows Qiagen's Change in Accured Expenses stood at -$33.9 million in 2021, then tumbled by 56.81% to -$53.1 million in 2022, then soared by 141.72% to $22.2 million in 2023, then fell by 5.86% to $20.9 million in 2024, then soared by 54.18% to $32.2 million in 2025.
  • Its last three reported values are $32.2 million in Q4 2025, $399.0 million for Q3 2025, and $486.8 million during Q2 2025.